Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (7)
  • 2025 (59)
  • 2024 (43)
  • 2023 (80)
  • 2022 (102)
  • 2021 (81)
  • 2020 (16)
  • 2019 (22)
  • 2018 (7)
  • 2017 (3)
  • 2003 (1)

Subject

  • Drug Trafficking (4205)
  • Synthetic drugs (1139)
  • Guns/Weapons (1038)
  • OCDETF/Task Force (820)
  • Fake Pills (688)
  • Arrests/Convictions - Major (643)
  • Guilty Plea (557)
  • Seizures (Drugs/Property) (482)
  • Overdose (327)
  • Major Law Enforcement Operation (277)
  • Diversion Division (254)
  • Take Back Day (246)
  • Task Forces/Task Force Officers (237)
  • Pharmaceuticals/Pharmacists/Physicians (228)
  • Money Laundering (218)
  • Gangs (202)
  • Outreach/Drug Prevention (188)
  • Fentanyl Awareness (166)
  • One Pill Can Kill (118)
  • HIDTA (105)
  • Press Conferences (68)
  • Narcoterrorism (55)
  • Extraditions (52)
  • Public and Media Affairs - also see Congressional Affairs (51)
  • Fentanyl Free America (39)
  • Counterfeit Pills (38)
  • Asset Forfeiture (30)
  • Dark Web- Internet Trafficking (29)
  • International/Foreign Operations (28)
  • Red Ribbon (27)
  • Congressional Affairs (15)
  • Terrorism (14)
  • Campaigns (13)
  • Other (12)
  • Critical Incident (9)
  • Intergovernmental Affairs (9)
  • Cartel (6)
  • Intelligence Division - Intelligence Products (5)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Prescription Drugs (371)
  • Prevention/Education - DEA websites GSAD, JTT etc (54)

Drug Name

  • Oxycodone (80)
  • Fentanyl (74)
  • Opioids (64)
  • Synthetic Opioids (29)
  • Methamphetamine (22)
  • Hydromorphone (21)
  • Benzodiazepines (14)
  • Morphine (11)
  • Amphetamines (10)
  • Cocaine (9)
  • Heroin (6)
  • Methadone (6)
  • Marijuana (Cannabis) (4)
  • Steroids (3)
  • Ketamine (2)
  • GHB (1)
  • Marijuana Concentrates (1)
  • Psilocybin (1)

Field Division

  • Washington, DC (52)
  • St. Louis (42)
  • New York (37)
  • Sede (30)
  • Seattle (26)
  • New England (25)
  • El Paso (20)
  • Atlanta (19)
  • Miami (19)
  • New Jersey (19)
  • Omaha (19)
  • Chicago (17)
  • Dallas (16)
  • Houston (12)
  • San Francisco (12)
  • Louisville (10)
  • New Orleans (10)
  • Los Angeles (9)
  • San Diego (9)
  • Rocky Mountain (7)
  • Phoenix (6)
  • Detroit (3)
  • Philadelphia (2)
Clear All Results
421 Results - Showing 251 to 260
PRESS RELEASE

Consent Decree Approved Between the United States and Baltimore-Based Pharmacy and Pharmacist Alleged to Have Illegally Dispensed Controlled Substances

Baltimore, Md. - U.S. District Judge Richard D. Bennett approved the United States’ consent decree with Ketan K. Dankhara, a Baltimore-based pharmacist, and Falls RX, LLC d/b/a Ultra Care Pharmacy Baltimore (“Ultra Care”), resolving the United States’ civil allegations that Dankhara and Ultra Care violated the Controlled Substances Act (“CSA”)...
PRESS RELEASE

DEA El Paso Recognizes First Ever National Fentanyl Awareness Day

El Paso – In an effort to save lives, DEA is proud to join “Song for Charlie” and other valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat that fentanyl...
PRESS RELEASE

DEA Recognizes First Ever National Fentanyl Awareness Day

SAN DIEGO – In an effort to save lives, DEA is proud to join “Song for Charlie” and many of our valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat...
PRESS RELEASE

DEA Recognizes First Ever National Fentanyl Awareness Day

WASHINGTON – In an effort to save lives, DEA is proud to join “Song for Charlie” and many of our valued public health, non-profit, and law enforcement partners in recognizing the first ever National Fentanyl Awareness Day. This day is an effort to educate individuals around the dangerous threat that...
PRESS RELEASE

Montgomery County Drug Dealer Pleads Guilty to Distribution of Fentanyl that Led to an Overdose Death

Greenbelt, Md – Enitan Mouroukeji Agbi, a/k/a “Anton Agbi,” and “Tone,” age 38, of Germantown, Maryland, pleaded guilty yesterday to distribution of fentanyl. Agbi admitted that Victim 1 died as a result of using drugs that Agbi distributed. The guilty plea was announced by Jarod Forget, Special Agent in Charge...
PRESS RELEASE

DEA Launches First Year of Operation Engage in Richmond, VA

Richmond, Va., – Today, the Drug Enforcement Administration's (DEA) Washington Division announces the launch of Operation Engage in Richmond, Virginia. Operation Engage is comprehensive, community-level initiative, implemented to target and address the drug and related violence issues in cities with high levels of drug related problems. Operation Engage is new...
PRESS RELEASE

La DEA Inicia el Primer Año de la Operación Engage en Richmond, VA

Richmond, Virginia – Hoy, la División de Washington de la Administración para el Control de Drogas (DEA, por sus siglas en inglés) anunció el inicio de la Operación Engage en Richmond, Virginia. La cual es una iniciativa integral a nivel comunitario implementada para combatir y abordar los problemas asociados a...
PRESS RELEASE

Richland Physician Sentenced for Conspiring to Distribute Medically Unnecessary Fentanyl Patches, Opioid Pills and Other Controlled Substances

SPOKANE, Wash. – Senior U.S. District Judge Edward F. Shea has sentenced Dr. Janet Sue Arnold, age 63, of Benton City, Washington, to 48 months in federal prison for conspiring to distribute and possess with intent to distribute opioid pain medications and other controlled substances without a legitimate medical purpose...
PRESS RELEASE

Two Naturopaths Agree to Pay $32,000 in Civil Penalties For Improper Prescription of Opioids and Controlled Substances

SPOKANE, Wash.– Dr. Jacqueline Thomas, N.D., an East Wenatchee-based naturopathic doctor, and Dr. Rebecka Hoppins, an Edmonds-based naturopathic doctor, have each agreed to pay $16,500 to resolve allegations under the Controlled Substances Act that they improperly prescribed controlled substances. The Controlled Substances Act regulates certain drugs deemed to pose a...
PRESS RELEASE

Former El Paso Physician Agrees to Pay $350,000 to Resolve Allegations

EL PASO, Texas – Dr. Herbert Nassour, a former physician in El Paso, has agreed to pay $350,000 under a civil settlement to resolve allegations he violated certain provisions of the Controlled Substances Act (CSA). Dr. Nassour was a physician registered with the Drug Enforcement Administration (DEA) to prescribe and...

Paginación

  • Primera página «
  • Anterior
  • Page 22
  • Page 23
  • Page 24
  • Page 25
  • Current page 26
  • Page 27
  • Page 28
  • Page 29
  • Page 30
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster